Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.858 |
High Similarity |
NPD6166 |
Phase 2 |
0.858 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8313 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8235 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8229 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8167 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8114 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8103 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.809 |
Intermediate Similarity |
NPD8312 |
Approved |
0.809 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8068 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8059 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8049 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8035 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8011 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7955 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7941 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7933 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7877 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7661 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7622 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7611 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD3226 |
Approved |
0.76 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD3750 |
Approved |
0.753 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7473 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7439 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD943 |
Approved |
0.7419 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6776 |
Approved |
0.732 |
Intermediate Similarity |
NPD6779 |
Approved |
0.732 |
Intermediate Similarity |
NPD6780 |
Approved |
0.732 |
Intermediate Similarity |
NPD6781 |
Approved |
0.732 |
Intermediate Similarity |
NPD6777 |
Approved |
0.732 |
Intermediate Similarity |
NPD6778 |
Approved |
0.732 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1240 |
Approved |
0.731 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7296 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7287 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7245 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7236 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7182 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7175 |
Intermediate Similarity |
NPD37 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7129 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7129 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7069 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7069 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7041 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7024 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7021 |
Intermediate Similarity |
NPD7240 |
Approved |
0.6994 |
Remote Similarity |
NPD1203 |
Approved |
0.6994 |
Remote Similarity |
NPD1470 |
Approved |
0.6983 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6978 |
Remote Similarity |
NPD919 |
Approved |
0.6977 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6941 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD8319 |
Approved |
0.6915 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD2309 |
Approved |
0.6897 |
Remote Similarity |
NPD6190 |
Approved |
0.689 |
Remote Similarity |
NPD2797 |
Approved |
0.6886 |
Remote Similarity |
NPD411 |
Approved |
0.6886 |
Remote Similarity |
NPD3268 |
Approved |
0.6871 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6866 |
Remote Similarity |
NPD7680 |
Approved |
0.6852 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD1201 |
Approved |
0.6836 |
Remote Similarity |
NPD6273 |
Approved |
0.6825 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6825 |
Remote Similarity |
NPD7907 |
Approved |
0.6823 |
Remote Similarity |
NPD8053 |
Approved |
0.6823 |
Remote Similarity |
NPD8054 |
Approved |
0.6818 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD9717 |
Approved |
0.6809 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6789 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6769 |
Remote Similarity |
NPD4287 |
Approved |
0.6765 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.675 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.673 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.673 |
Remote Similarity |
NPD4665 |
Approved |
0.6721 |
Remote Similarity |
NPD4288 |
Approved |
0.6719 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD1608 |
Approved |
0.6707 |
Remote Similarity |
NPD9494 |
Approved |
0.6706 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6704 |
Remote Similarity |
NPD920 |
Approved |
0.6702 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6686
|
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |